M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Iron status and self‐reported fatigue in blood donors
TL;DR: An observational analysis of data from the STRIDE randomized trial to evaluate association of iron status with self‐reported fatigue found no conclusive link.
Posted ContentDOI
Trends in CD4 and viral load testing 2005 to 2018: Multi-cohort study of people living with HIV in Southern Africa
Elizabeth Zaniewski,Cam Ha Dao Ostinelli,Frédérique Chammartin,Nicola Maxwell,Mary-Ann Davies,Jonathan Euvrard,Janneke van Dijk,Samuel Bosomprah,Samuel Bosomprah,Sam Phiri,Frank Tanser,Frank Tanser,Nosisa Sipambo,Josephine Muhairwe,Geoffrey Fatti,Hans Prozesky,Robin Wood,Nathan Ford,Matthew P. Fox,Matthias Egger,Matthias Egger +20 more
TL;DR: CD4 cell counting declined over time, including testing at the start of ART, despite the fact that many patients still initiated ART with advanced HIV disease, threatening the effectiveness of ART in sub-Saharan Africa.
Journal ArticleDOI
Resolving design problems in equivalency trials
Matthew P. Fox,LeAnne M. Fox +1 more
TL;DR: Design methods for equivalency trials that can substantially increase confidence in claims of equivalence are explored, including how, with commonly used methods, antibiotic equivalency Trials often show that 2 drugs are equivalent when strong differences truly exist.
Journal ArticleDOI
Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir.
R. De Waal,Karen Cohen,Matthew P. Fox,Matthew P. Fox,Kathryn Stinson,Kathryn Stinson,Gary Maartens,Andrew Boulle,Davies Mr +8 more
TL;DR: Kidney function recovered in most patients who continued to receive tenofovir despite a CrCl <50 mL/min, andCreatinine monitoring is feasible where access to laboratory services is good, and further research is needed to determine how best to monitor renal function in resource-limited settings.
Journal ArticleDOI
Tracing people living with HIV who are lost to follow-up at ART programs in Southern Africa: A sampling-based cohort study in six countries.
Marie Ballif,Benedikt Christ,Nanina Anderegg,Frédérique Chammartin,Josephine Muhairwe,Laura F. Jefferys,Jonas Hector,Janneke van Dijk,Michael J. Vinikoor,Monique van Lettow,Cleophas Chimbetete,Sam Phiri,Dorina Onoya,Matthew P. Fox,Matthew P. Fox,Matthias Egger,Matthias Egger,Matthias Egger +17 more
TL;DR: In this article, the authors examined outcomes of people living with HIV (PLHIV) lost to follow-up (LTFU) 2014-2017 at ART programs in Southern Africa.